News

Filter by:

Limit to items where the date of the news item:
Date range
Limit to items where the date of the news item:
Limit to news where the title matches:
Limit to news items tagged with one or more of:
Limit to news items where the audience is one or more of:

To School of Pharmacy assistant professors Brett Barrett and Kelly Grindrod, that is a problem. Antibiotics are effective tools for fighting infectious diseases, but misinformation surrounds when and why they should be used. The public lecture delivered by Grindrod and Barrett on November 12th acknowledged the important contribution antibiotics have made and continue to make to human health and addressed the many myths surrounding the medications.

With the funding from Ride for Dad and an impressive team of research partners, School of Pharmacy Professor Shawn Wettig’s research is set to take a big step forward, from the petri dish to real cancer cases. The Ride for Dad foundation has committed $104,000 to help Wettig and collaborators fine-tune a treatment that utilizes irradiated gold nanoparticles to target prostate cancer, one the most common cancer among Canadian men. The goal is to shorten treatment duration and reduce side effects, by delivering a more targeted treatment at a lower dose.

As Alzheimer’s disease continues to impact more and more Canadians, the need for novel therapies and therapeutic drugs is greater than ever. Using a state-of-the-art technology to discover new therapies to treat Alzheimer’s disease is among the projects receiving funding from the Canada Foundation for Innovation (CFI), announced today.

Like many other tools, sometimes prescription drugs can be used for more than one purpose. University of Waterloo scientists and industry partner Cyclica discovered that a commonly known antidepressant may be useful in fighting some of the symptoms of Alzheimer's disease.

Fourth-year Pharmacy student Holly Meginnis has been recognized with the Ontario Pharmacists Association (OPA) Student of Distinction Award for leadership and commitment to advancing the profession.